Targeting nanoparticles rotate faster and move across larger areas
Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can only work if the drug hits its target.
A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets — by simply analyzing each nanoparticle’s distinct movements in real time.
By studying drug-loaded gold nanostars on cancer cell membranes, the researchers found that nanostars designed to target cancer biomarkers transited over larger areas and rotated much faster than their non-targeting counterparts. Even when surrounded by non-specifically adhered proteins, the targeting nanostars maintained their distinct, signature movements, suggesting that their targeting ability remains uninhibited.
“Moving forward, this information can be used to compare how different nanoparticle characteristics — such as particle size, shape and surface chemistry — can improve the design of nanoparticles as targeting, drug-delivery agents,” said Northwestern’s Teri Odom, who led the study.
The study published today (Aug. 9) in the journal ACS Nano. Odom is the Charles E. and Emma H. Morrison Professor of Chemistry in Northwestern’s Weinberg College of Arts and Sciences.
The medical field has long been searching for alternatives to current cancer treatments, such as chemotherapy and radiation, which harm healthy tissues in addition to diseased cells. Although these are effective ways to treat cancer, they carry risks of painful or even dangerous side effects. By delivering drugs directly into the diseased area — instead of blasting the whole body with treatment — targeted delivery systems result in fewer side effects than current treatment methods.
“The selective delivery of therapeutic agents to cancer tumors is a major goal in medicine to avoid side effects,” Odom said. “Gold nanoparticles have emerged as promising drug-delivery vehicles that can be synthesized with designer characteristics for targeting cancer cells.”
Various proteins, however, tend to bind to nanoparticles when they enter the body. Researchers have worried that these proteins might impede the particles’ targeting abilities. Odom and her team’s new imaging platform can now screen engineered nanoparticles to determine if their targeting function is retained in the presence of the adhered proteins.
Learn more: Nanoparticles’ movement reveals whether they can successfully target cancer
The Latest on: Drug-delivery nanoparticles
[google_news title=”” keyword=”drug-delivery nanoparticles” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug-delivery nanoparticles
- Ultrasensitive photonic crystal detects single particles down to 50 nanometerson April 24, 2024 at 12:49 pm
Using an ultrasensitive photonic crystal, TU/e researchers were able to detect single particles down to 50 nanometers in diameter. The new research has just been published in the journal Optica.
- Engineering Powerful Vaccines with Lipid Nanotechnologyon April 21, 2024 at 6:15 am
In this, lipid nanoparticle (LNP) technology has emerged as highly promising. Progress in medical science has facilitated the seamless integration of lipid nanotechnology into standard therapy, ...
- Nanotechnology in Therapeuticson April 20, 2024 at 5:00 pm
Although progress in the application of nanotechnology to drug delivery has been dramatic and successful, as evidenced by some nanodrugs now on the market, several main challenges remain in this ...
- Drug delivery articles from across Nature Portfolioon April 16, 2024 at 5:01 pm
Using nanoparticles featuring anisotropic characteristics is a promising approach to developing multifunctional platforms for drug delivery and theranostics. This Review discusses methods to ...
- Drug delivery innovations push forth women’s healthon April 11, 2024 at 3:09 am
From nanoparticles to transdermal patches, Pharmaceutical Technology takes a look at the latest in drug delivery technologies for women's health.
- Nanotechnology in Therapeuticson April 5, 2024 at 5:00 pm
Nanomedicine. 2012;7(8):1253-1271. Liposomes Liposomes are self-assembled artificial vesicles developed from amphiphilic phospholipids. These vesicles consist of a spherical bilayer structure ...
- Biocompatible nanoparticles modified with ATP can enhance systemic delivery of cancer immunotherapyon March 27, 2024 at 10:01 am
The nanoparticles slowly release drugs that ... Moreover, the carriers traditionally used in local drug delivery offer limited utility in systemic application because they may not be compatible ...
- Purdue researchers create biocompatible nanoparticles to enhance systemic delivery of cancer immunotherapyon March 26, 2024 at 5:00 pm
Moreover, the carriers traditionally used in local drug delivery offer limited utility in systemic application because they may not be compatible with blood components.” Yeo and her colleagues used ...
- Department of Mechanical and Materials Engineeringon November 6, 2023 at 7:21 pm
For recent publications click here or here. Polymer nanoparticles and nanogels are developed for theranostic applications. We work on incorporating drug, RNAs, and iron oxide or metal nano-clusters ...
- Nature’s Lipid Nanoparticles: Exosomes in Drug Delivery and Therapeuticson February 28, 2023 at 5:55 pm
Exosomes have emerged as one of the most recent promising platforms for drug delivery and therapeutics for a wide range ... capabilities allow them to function as superior natural nanoparticles. Don't ...
via Bing News